Towards a consensus definition of immune exclusion in cancer

por Tiwari, Ankur, Oravecz, Tamas, Dillon, Laura A., Italiano, Antoine, Audoly, Laurent, Fridman, Wolf Hervé, Clifton, Guy Travis
Publicado 2023

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

por McCarthy, Patrick M., Valdera, Franklin A., Smolinsky, Todd R., Adams, Alexandra M., O’Shea, Anne E., Thomas, Katryna K., Van Decar, Spencer, Carpenter, Elizabeth L., Tiwari, Ankur, Myers, John W., Hale, Diane F., Vreeland, Timothy J., Peoples, George E., Stojadinovic, Alex, Clifton, Guy T.
Publicado 2023

Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinic...

por Adams, Alexandra M., Carpenter, Elizabeth L., Clifton, Guy T., Vreeland, Timothy J., Chick, Robert C., O’Shea, Anne E., McCarthy, Patrick M., Kemp Bohan, Phillip M., Hickerson, Annelies T., Valdera, Franklin A., Tiwari, Ankur, Hale, Diane F., Hyngstrom, John R., Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Shaheen, Montaser F., Yu, Xianzhong, Wagner, Thomas E., Faries, Mark B., Peoples, George E.
Publicado 2022

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

por Carpenter, Elizabeth Lee, Van Decar, Spencer, Adams, Alexandra M, O’Shea, Anne E, McCarthy, Patrick, Chick, Robert Connor, Clifton, Guy Travis, Vreeland, Timothy, Valdera, Franklin A, Tiwari, Ankur, Hale, Diane, Kemp Bohan, Phillip, Hickerson, Annelies, Smolinsky, Todd, Thomas, Katryna, Cindass, Jessica, Hyngstrom, John, Berger, Adam C, Jakub, James, Sussman, Jeffrey J, Shaheen, Montaser F, Yu, Xianzhong, Wagner, Thomas E, Faries, Mark, Peoples, George E
Publicado 2023